Log in to save to my catalogue

Individualised monitoring of patients with metastatic melanoma using plasma DNA

Individualised monitoring of patients with metastatic melanoma using plasma DNA

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1881768619

Individualised monitoring of patients with metastatic melanoma using plasma DNA

About this item

Full title

Individualised monitoring of patients with metastatic melanoma using plasma DNA

Publisher

London: Elsevier Ltd

Journal title

The Lancet (British edition), 2017-02, Vol.389, p.S99-S99

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

Abstract Background Circulating tumour DNA (ctDNA) is released by cancer cells into the bloodstream, which can be analysed via liquid biopsy. Analysis of liquid biopsy samples provides a real-time snapshot of tumour burden. After treatment, ctDNA concentrations can be low, making detection challenging. To study clonal evolution during treatment in...

Alternative Titles

Full title

Individualised monitoring of patients with metastatic melanoma using plasma DNA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1881768619

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1881768619

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(17)30495-6

How to access this item